Assignee
CORBUS PHARMACEUTICALS INC
US·6 granted patents·12 pending applications·11 citations·filing 2016–2025
Top patents by PatentIndex Score
18 records- 0188US9820964B2Ultrapure tetrahydrocannabinol-11-oic acidsCORBUS PHARMACEUTICALS INC·Filed 2016·Granted Nov 21, 2017·5 cites·21 claims
- 0284US10154986B2Ultrapure tetrahydrocannabinol-11-oic acidsCORBUS PHARMACEUTICALS INC·Filed 2017·Granted Dec 18, 2018·3 cites·16 claims
- 0378US10369131B2Ultrapure tetrahydrocannabinol-11-oic acidsCORBUS PHARMACEUTICALS INC·Filed 2018·Granted Aug 6, 2019·1 cites·16 claims
- 0477US9801849B2Ultrapure tetrahydrocannabinol-11-oic acidsCORBUS PHARMACEUTICALS INC·Filed 2016·Granted Oct 31, 2017·1 cites·18 claims
- 0576US11052066B2Ultrapure tetrahydrocannabinol-11-oic acidsCORBUS PHARMACEUTICALS INC·Filed 2019·Granted Jul 6, 2021·0 cites·18 claims
- 0675US10085964B2Ultrapure tetrahydrocannabinol-11-oic acidsCORBUS PHARMACEUTICALS INC·Filed 2016·Granted Oct 2, 2018·1 cites·19 claims
- 0775US2022117931A1Ultrapure tetrahydrocannabinol-11-oic acidsCORBUS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0863US2026092038A1Cannabinoid receptor 1 antagonists/inverse agonists and uses thereofCORBUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0961US2025195647A1ANTI-alpha-V-beta-8 INTEGRIN ANTIBODIES AND USES THEREOFCORBUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1058US2020405687A1Methods for the treatment of infectionCORBUS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1157US2025248973A1Cannabinoid receptor 1 antagonists/inverse agonists and uses thereofCORBUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1253US2017022179A1Compositions, dosages, and methods of using tetrahydrocannabinol derivativesCORBUS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1349US2023339880A1Compositions of ajulemic acid and uses thereofCORBUS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1447US2018116999A1Methods of treating fibrotic diseases using tetrahydrocannabinol-11-oic acidsCORBUS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1546US2019133995A1Methods for the treatment of infectionCORBUS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1643US2021198223A1Methods and compositions relating to ultrapure 5-(1,1-dimethylheptyl)-resorcinolCORBUS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1743US2016367518A1Methods of treating fibrotic diseases using tetrahydrocannabinol-11-oic acidsCORBUS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1842US2021284621A1Cannabinoids and uses thereofCORBUS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →